IL6 and cancer: The discovery that IL-6-activated STAT3 transcription factors form phase-separated biomolecular condensates in the cytoplasm and the nucleus provide a novel basis for targeting such STAT3 nanodroplet and condensate biochemistry in the cytoplasm and/or the nucleus for anti-cancer therapeutics.